GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect & identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, & state-of-the-art computer science & data science to enhance the scientific understanding of cancer biology, & to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, & the United Kingdom. GRAIL is a wholly-owned subsidiary of Illumina (NASDAQ:ILMN). For more information, please visit www.grail.com
As a Computational Biologist/Bioinformatics Scientist, you will analyze some of the largest, the richest genomic datasets in the world to find biological signals & patterns & guide our assays, bioinformatics pipelines, & product strategies. Working closely with other scientists, clinicians, & engineers, you will develop novel methods & employ existing tools to investigate the biology of tumor-derived cell-free DNA, & how that relates to the performance of tests, products, & machine learning solutions for clinical oncology applications. You will complete statistical analyses operating across GRAIL's datasets & data from collaborators in academia & industry. Your analyses will result in exciting discoveries in cancer biology, impactful publications, & products for the early detection of or support for patients with cancer.